» Articles » PMID: 27141859

No Effect of AR PolyG Polymorphism on Spinal and Bulbar Muscular Atrophy Phenotype

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2016 May 5
PMID 27141859
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Disease severity varies considerably among patients with Spinal and Bulbar Muscular Atrophy (SBMA). Our aim was to investigate the role of androgen receptor (AR) polymorphic repeats in SBMA phenotype.

Methods: We analyzed the length of AR polyQ and polyG tracts in 159 SBMA patients.

Results: No relationship between polyG size or polyG/polyQ haplotypes and clinical phenotype was found. An independent negative correlation between polyQ-length and onset of weakness was confirmed (P < 0.001).

Conclusions: The negative results of our study prompt to continue the search for potential disease modifiers in SBMA outside the AR gene.

Citing Articles

The evolution and polymorphism of mono-amino acid repeats in androgen receptor and their regulatory role in health and disease.

Meszaros A, Ahmed J, Russo G, Tompa P, Lazar T Front Med (Lausanne). 2022; 9:1019803.

PMID: 36388907 PMC: 9642029. DOI: 10.3389/fmed.2022.1019803.


The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

Pradat P, Bernard E, Corcia P, Couratier P, Jublanc C, Querin G Orphanet J Rare Dis. 2020; 15(1):90.

PMID: 32276665 PMC: 7149864. DOI: 10.1186/s13023-020-01366-z.


ATXN1 N-terminal region explains the binding differences of wild-type and expanded forms.

Rocha S, Vieira J, Vazquez N, Lopez-Fernandez H, Fdez-Riverola F, Reboiro-Jato M BMC Med Genomics. 2019; 12(1):145.

PMID: 31655597 PMC: 6814966. DOI: 10.1186/s12920-019-0594-4.


Preliminary design and validation of the "6-K-scale" for bulbar symptoms evaluation in SBMA.

Giorgia Q, Irene B, Laura M, Ilaria M, Cinzia B, Elena P Neurol Sci. 2019; 40(7):1393-1401.

PMID: 30915613 DOI: 10.1007/s10072-019-03850-2.